Scientists have developed a revolutionary laser treatment to prevent blindness. This non-invasive therapy uses ultra-short ...

The clinical trial enrolled 38 adults aged 60 and older who had advanced geographic atrophy, the late stage of macular ...

Macular degeneration, particularly age-related macular degeneration, is a leading cause of vision loss worldwide. This condition affects the central part of the retina, known as the macula, which is ...

Coave Therapeutics unveils lead gene therapy program for retinal vascular diseases, powered by first-in-class vector for ...

HAYWARD, Calif., Feb. 28, 2025 /PRNewswire/ -- Avirmax Biopharma, Inc., a leader in developing the next generation of AAV gene therapies, today announced the commencement of Investigational New Drug ...

Retinal diseases such as age-related macular degeneration (AMD) and diabetic retinopathy affect millions of people globally, often leading to vision loss with minimal straightforward treatment.

Toll-like receptors, or TLRs, are the immune system’s early warning sensors. They detect microbial invaders and damage signals, helping the body mount a defense. But when TLR signaling veers off ...

Our task now is to translate that advantage into stopping more people from becoming blind by offering a product that is easier to use and works better.” — Filamon CEO, Dr Graham Kelly SYDNEY, NSW, ...